NASDAQ:REVB | Free Cash Flow | REVELATION BIOSCIENCES, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.21M$71,879.00-$3.29M
2025-12-31-$1.97M
2025-03-31-$2.79M
2024-12-31-$3.75M-$17,689.00-$3.77M
2024-03-31-$2.84M$19,172.00-$2.86M
2023-12-31-$2M
2023-03-31-$1.58M$0.00-$1.58M-25.57%
2022-12-31-$947,467.00
2022-03-31-$4.83M
2021-12-31-$2.88M-$16,153.00-$2.9M
2021-03-31-$2.38M$99,101.00-$2.48M
2020-12-31-$208,115.00
2020-03-31$14,691.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$8.27M
2024-12-31-$18.32M$19,171.00-$18.34M
2023-12-31-$7.29M
2022-12-31-$11.22M
2021-12-31-$11.09M$131,963.00-$11.22M
2020-12-31-$216,664.00